Tag: LEO Pharma

LEO Pharma Announced Acquisition of Exclusive Rights to Develop and Market Brodalumab

leo-pharma
LEO Pharma A/S, a global leader in medical dermatology, announced it has acquired the exclusive rights to develop and market brodalumab (marketed as Kyntheum® in the European Union) for the treatment ...

LEO Pharma Acquired Bayer’s Global Prescription Dermatology Business

LEO Pharma and Bayer announced the achievement of the relevant closing conditions to allow the transfer of Bayer’s global prescription dermatology business to LEO Pharma. The companies first announced...

Evotec sets up a drug discovery alliance with LEO Pharma

pharma
Evotec AG (Germany) announced a new integrated drug discovery alliance with LEO Pharma (Denmark), a global leader in medical dermatology.

LEO Pharma signed a global licensing agreement with JW Pharmaceutical

leo-pharma
LEO Pharma A/S (Denmark) and JW Pharmaceutical (South Korea) announced, that they have signed a global licensing agreement for JWP’s novel atopic dermatitis drug candidate, JW1601.

LEO Pharma will gain Bayer’s prescription dermatology portfolio

leo-pharma
The portfolio to be acquired includes branded topical prescription treatments for acne, fungal skin infections and rosacea, and a range of topical steroids.